| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 10/21/2004 | WO2004089384A1 Remedy or preventive for low turnover bone diseases |
| 10/21/2004 | WO2004089359A1 Composition for inhibition or prevention of bone density lowering and refreshment therefor |
| 10/21/2004 | WO2004052888B1 Tropane esters and methods for producing and using them |
| 10/21/2004 | WO2004009556A9 4-(substituted aryl)-5-hydroxyisoquinolinone derivative |
| 10/21/2004 | WO2003096980A3 Bicyclic modulators of androgen receptor function |
| 10/21/2004 | WO2003062241A8 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function |
| 10/21/2004 | WO2003045228A3 Methods for treating autoimmune disorders, and reagents related thereto |
| 10/21/2004 | US20040210080 3-(oxo, oxime, hydrazone, or alkylidene)-fluorene derivatives; can be synergistically combined with other anticarcinogenic, anticholesterol, anxiolytic agents, antidepressants or enzyme inhibitors; bone disorders |
| 10/21/2004 | US20040210052 Efficient synthesis of 5-heteroatom-containing-pyrazoles |
| 10/21/2004 | US20040209959 X-Y, in which X is a benzyl group, a saturated or unsaturated cycloalkyl group or a non-cyclic, straight or branched alkyl group, optionally in combination with another analgesic, such as an NSAID or an opioid. |
| 10/21/2004 | US20040209937 Treatment of excessive osteolysis with indolinone compounds |
| 10/21/2004 | US20040209934 Protein phosphate inhibitors |
| 10/21/2004 | US20040209922 Pyridine matrix metalloproteinase inhibitors |
| 10/21/2004 | US20040209914 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 10/21/2004 | US20040209908 New derivatives of hydantoins, thiohydantoins, pyrimidinediones and thioxopyrimidinones, their preparation processes and their use as medicaments |
| 10/21/2004 | US20040209904 Substituted quinazoline compounds useful as P38 kinase inhibitors |
| 10/21/2004 | US20040209903 Substituted 7-azaquinazoline compounds useful as p38 kinase inhibitors |
| 10/21/2004 | US20040209901 substituted 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds, e.g., 8-(2,6-Difluoro-phenyl)-4-(4-fluoro-2-methyl-phenyl)-2-(2-hydroxy-1-hydroxymethyl-ethylamino)-8H-pyrido[2,3-d]pyrimidin-7-one; CSBP/p38 kinase inhibitors. |
| 10/21/2004 | US20040209894 e.g., 1-(4-chloroanilino)-4-[2-(pyridin-3-yl)-ethyl]-isoquinoline and 5-[4-(tert-butyl)-anilino]-8-[(6-methoxy-pyridin-3-yl)-methyl]-[1,6]naphthyridine |
| 10/21/2004 | US20040209879 Piperidinyl derivates as modulators of chemokine receptor activity |
| 10/21/2004 | US20040209874 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE) |
| 10/21/2004 | US20040209868 Substituted indoles |
| 10/21/2004 | US20040209856 Oral pharmaceutical products containing 17beta-estradiol-3-lower alkanoate, method of administering the same and process of preparation |
| 10/21/2004 | US20040209848 Administering to a patient (11 alpha , 15 alpha , 13E)-9-oxo-11,15-dihydroxy- 16-(3-methoxymethylphenyl)-17, 18, 19, 20-tetranor-5-thiaprost-13-enoic acid methyl ester, or cyclodextrin clathrate for treating osteoporosis |
| 10/21/2004 | US20040209845 Novel styrylacrylonitrile compounds which are useful in treating a variety of cell proliferative disorders such as cancer and specifically acute lymphoblastic leukemia; (E,E)-2-(benzylamido)-3-styrylacrylonitrile for example |
| 10/21/2004 | US20040209832 RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA) |
| 10/21/2004 | US20040209813 Caspase inhibitors for inhibiting blood cell proliferation and for treating autoimmune diseases |
| 10/21/2004 | US20040209799 comprises inhibitors (cytokines) of janus kinases (JAK)/signal transducers and activators of transcription (STAT) other than debromohymenialdisine and hymensialdisine; gene expression inhibition; bioassay, immunoassay, drug screening; for treatment of degenerative joint diseases such as osteoarthritis |
| 10/21/2004 | US20040209798 biodrugs for treatment of lung cancer, glioma, anorexia, hypothyroidism, hyperaldosteronism, H. pylori proliferation, acromegaly, restenosis, Crohn's disease, systemic sclerosis, external and internal pancreatic pseudocysts and ascites |
| 10/21/2004 | US20040209359 Freeze-dried biocompatible matrix/biological scaffold comprising plasma proteins for use as implants in tissue engineering and biotechnology; wound healing agents |
| 10/21/2004 | US20040208944 Compositions and methods against inflammatory processes |
| 10/21/2004 | US20040208924 active pharmaceutical ingredient is for example [(2S)-Sulfanyl-5-[(N,N-dimethylamino)acetyl]aminopentanoyl-L-leucyl-L-tert-leucine N-methylamide; bonding strength, stability |
| 10/21/2004 | US20040208844 Products and drug delivery vehicles |
| 10/21/2004 | US20040208822 technetium labelled complexes; for the treatment or diagnosis of pathologies caused by attack on human cartilage, arthritis |
| 10/21/2004 | CA2521602A1 Therapeutic composition for autoimmune conditions |
| 10/21/2004 | CA2521384A1 New carbamoyl-and thiocarbamoyl-phosphonates and pharmaceutical compositions comprising them |
| 10/21/2004 | CA2521340A1 Aminopyrimidine derivatives and their medical use |
| 10/21/2004 | CA2520770A1 Agent for treating or preventing low-turnover bone diseases |
| 10/20/2004 | EP1468991A1 Imides as PDE III, PDE IV and TNF inhibitors |
| 10/20/2004 | EP1468091A2 Transmembrane protein |
| 10/20/2004 | EP1468020A2 Multimers of receptor-binding ligands |
| 10/20/2004 | EP1468019A2 Secreted protein |
| 10/20/2004 | EP1468018A2 Leptin proteins |
| 10/20/2004 | EP1467998A1 Tetracyclic heterocompounds as estrogen receptor modulators |
| 10/20/2004 | EP1467995A2 Pyrrolopyrimidine a2b selective antagonist compounds, their synthesis and use |
| 10/20/2004 | EP1467982A1 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them, and uses thereof |
| 10/20/2004 | EP1467979A2 FUSED HETEROCYCLIC COMPOUNDS AND ANALOGS THEREOF: MODULATORS OF NUCLEAR HORMONE RECEPTOR FUNCTION |
| 10/20/2004 | EP1467976A1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 10/20/2004 | EP1467972A1 Indazole compounds useful as protein kinase inhibitors |
| 10/20/2004 | EP1467968A1 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters |
| 10/20/2004 | EP1467965A1 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters |
| 10/20/2004 | EP1467752A1 HUMAN MAST CELL−EXPRESSED MEMBRANE PROTEINS |
| 10/20/2004 | EP1467748A1 Stimulation of bone growth and cartilage formation with thrombing peptide derivatives |
| 10/20/2004 | EP1467745A2 Herbal composition for treating various disorders including psoriasis, a process for preparation thereof and method for treatment of such disorders |
| 10/20/2004 | EP1467741A1 Pharmaceutically acceptable phosphate-glycerol carrying bodies |
| 10/20/2004 | EP1467740A1 Phospholipid bodies and use thereof in the treatment of inflammatory and autoimmune diseases |
| 10/20/2004 | EP1467739A2 17-hydroxy-4-aza-androstan-3-ones as androgen receptor modulators |
| 10/20/2004 | EP1467731A1 3-(imidazolyl)-2-alkoxypropanoic acids as tafia inhibitors |
| 10/20/2004 | EP1467721A2 Substituted amine derivatives and their use for the treatment of angiogenesis |
| 10/20/2004 | EP1467714A1 Drug mixture with enhanced dissolution rate |
| 10/20/2004 | EP1467624A2 Methods of inducing or enhancing connective tissue repair |
| 10/20/2004 | EP1368327B1 Benzo thiadiazine matrix metalloproteinase inhibitors |
| 10/20/2004 | EP1263725B1 Novel compounds |
| 10/20/2004 | EP1230236B1 Compound with growth hormone releasing properties |
| 10/20/2004 | EP1171143B1 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising same |
| 10/20/2004 | EP1149074B1 Acetylenic sulfonamide thiol tace inhibitors |
| 10/20/2004 | EP1117416B1 Plant extracts for the treatment of increased bone resorption |
| 10/20/2004 | EP1112253B1 Branched alkyl pyrrolidine-3-carboxylic acids |
| 10/20/2004 | EP1005351B1 Aqueous metal bicarbonate solutions for the treatment of osteoarthritis |
| 10/20/2004 | CN1539019A Process for producing 1,4-dihydroxy-2-naphthoic acid |
| 10/20/2004 | CN1538970A Thieno [2,3-d] pyrimidinediones and use in modulation of autoimmune disease |
| 10/20/2004 | CN1538960A Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containint them |
| 10/20/2004 | CN1538959A Fused-polycyclic compounds |
| 10/20/2004 | CN1538951A Omega-aminoalkylamides of R-2-aryl-propionic acids as inhibitors of chemotaxis of polymorphonucleate and mononucleate cells |
| 10/20/2004 | CN1538851A Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, used thereof and method of making same |
| 10/20/2004 | CN1538850A BMP Binding proteins for use in bone or cartilage regenearation |
| 10/20/2004 | CN1538848A Novel Benzo-fused heterocycles |
| 10/20/2004 | CN1538844A Novel amides preparation used as modulators of CCR-receptor activity, its preparation and therapeutic use |
| 10/20/2004 | CN1538838A Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugs |
| 10/20/2004 | CN1538836A Substituted amine derivatives and method of use |
| 10/20/2004 | CN1537608A Traditional Chinese medicine for treating stiffness nape and shoulder disease |
| 10/20/2004 | CN1537606A Traditional Chinese medicine for treating bone injury |
| 10/20/2004 | CN1537595A Zuanshanfeng granule and its prepn. method |
| 10/20/2004 | CN1537594A Sugar-free type Zuanshanfeng mixture, and its prepn. method |
| 10/20/2004 | CN1537580A Honghua Qili tablet contg. safflower carthamus, and its prepn. method |
| 10/20/2004 | CN1537579A Qili capsule for treating traumatic injuries, and its prepn. method |
| 10/20/2004 | CN1537578A Granule for treating hyperosteogeny and its prepn. method |
| 10/20/2004 | CN1537573A Extraction of active ingredient of Zuanshanfeng, and method for preparing its prepn. |
| 10/20/2004 | CN1537572A Qili dispersing tablet for treating traumatic injuries, and its prepn. method |
| 10/20/2004 | CN1537571A Strong Rhizoma Gastrodiae and eucommia bark granule, and its prepn. method |
| 10/20/2004 | CN1537553A Traditional Chinese medicine for treating gout exelling |
| 10/20/2004 | CN1537531A Celecoxib compositions |
| 10/20/2004 | CN1171889C Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of P38 protein kinase |
| 10/20/2004 | CN1171888C Substituted purin derivatives, preparation method and use |
| 10/20/2004 | CN1171883C Nonsteroidal antiinflammatories |
| 10/20/2004 | CN1171872C Compounds for modulation of PPAP gamma activity |
| 10/20/2004 | CN1171870C Inhibitors of cysteine protease |
| 10/20/2004 | CN1171625C Ant-shuangshen Tongbi pill for treating rhematoid or rheumatic arthitis and ankylosing spondylitis |
| 10/20/2004 | CN1171617C Chinese medicine for treating cervical spondylosis |
| 10/20/2004 | CN1171616C Composite medicine for treating femoral head necrosis |